The Syrian pharmaceutical company “Tamico” is preparing to launch the drug “azithromycin” today on the market, which is a drug approved in the protocol for the treatment and prevention of the Corona virus.
The Syrian newspaper “Al-Watan” quoted a book by the Syrian Ministry of Industry in which it was stated that the new product is used to treat bronchitis and sinusitis, community-acquired pneumonia, and uncomplicated infections of the skin and skin.
It is also used in the treatment of pharyngitis, tonsillitis, genital ulcers in men, otitis media, sinusitis, and acquired pneumonia in children.
The ministry stated that the new product will be marketed to meet the local market’s demand for it.
Source: “Al Watan”
